Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

A new combination of tadalafil and finasteride improves drug performance and stability.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Persistent ED in Propecia users is not due to abnormal blood flow.

In 2005, men used finasteride mainly to treat an enlarged prostate.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Finasteride, a drug that changes testosterone to a different hormone, was studied and its effects over time were modeled successfully.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

New compounds may help treat prostate cancer by reducing cell growth.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.